These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9183305)

  • 1. The factor VR506Q mutation causing APC resistance is highly prevalent amongst unselected outpatients with clinically suspected deep venous thrombosis.
    Svensson PJ; Zöller B; Mattiasson I; Dahlbäck B
    J Intern Med; 1997 May; 241(5):379-85. PubMed ID: 9183305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
    Svensson PJ; Zöller B; Dahlbäck B
    Thromb Haemost; 1997 Feb; 77(2):332-5. PubMed ID: 9157592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis.
    Hillarp A; Zöller B; Svensson PJ; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):990-2. PubMed ID: 9308741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein c resistance (APC) and inherited factor V (FV) mis-sense mutation in patients with venous and arterial thrombosis in a haematology clinic.
    Ma DD; Aboud MR; Williams BG; Isbister JP
    Aust N Z J Med; 1995 Apr; 25(2):151-4. PubMed ID: 7605298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C resistance caused by a common factor V mutation has a single origin.
    Zöller B; Hillarp A; Dahlbäck B
    Thromb Res; 1997 Feb; 85(3):237-43. PubMed ID: 9058498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population study of the G1691A mutation (R506Q, FV Leiden) in the human factor V gene that is associated with resistance to activated protein C.
    Braun A; Müller B; Rosche AA
    Hum Genet; 1996 Feb; 97(2):263-4. PubMed ID: 8566967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V R506Q gene mutation analysis by PCR-RFLP: optimization, comparison with functional testing for resistance to activated protein C, and establishment of cell line controls.
    Voelkerding KV; Wu L; Williams EC; Hoffman SM; Sabatini LM; Borcherding WR; Huber S
    Am J Clin Pathol; 1996 Jul; 106(1):100-6. PubMed ID: 8701917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V R506Q mutation (activated protein C resistance) is an additional risk factor for early renal graft loss associated with acute vascular rejection.
    Ekberg H; Svensson PJ; Simanaitis M; Dahlbäck B
    Transplantation; 2000 Apr; 69(8):1577-81. PubMed ID: 10836365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location and extent of deep vein thrombosis in patients with and without FV:R 506Q mutation.
    Björgell O; Nilsson PE; Nilsson JA; Svensson PJ
    Thromb Haemost; 2000 May; 83(5):648-51. PubMed ID: 10823255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis.
    Brenner B; Zivelin A; Lanir N; Greengard JS; Griffin JH; Seligsohn U
    Blood; 1996 Aug; 88(3):877-80. PubMed ID: 8704244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries.
    Holm J; Zöller B; Berntorp E; Erhardt L; Dahlbäck B
    J Intern Med; 1996 Mar; 239(3):221-6. PubMed ID: 8772620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
    Margaglione M; Brancaccio V; De Lucia D; Martinelli I; Ciampa A; Grandone E; Di Minno G
    Chest; 2000 Nov; 118(5):1405-11. PubMed ID: 11083693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
    Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism.
    Bennet L; Odeberg H
    J Intern Med; 1998 Jul; 244(1):27-32. PubMed ID: 9698021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of functional testing for resistance to activated protein C and molecular biological testing for factor V R506Q in 370 patients.
    Montes MA; Fox EA; Longtine JA; Dorfman DM
    Arch Pathol Lab Med; 1998 Apr; 122(4):325-9. PubMed ID: 9648899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations.
    Castoldi E; Brugge JM; Nicolaes GA; Girelli D; Tans G; Rosing J
    Blood; 2004 Jun; 103(11):4173-9. PubMed ID: 14976057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.